Moolec (MLEC) - חוב להון עצמי

Moolec Science SA (MLEC) is transforming the alternative protein market by implementing the synthesis of animal proteins in GMO crops to reduce the cost of plant-based meat. This approach minimizes environmental damage and lowers the industry's carbon footprint. The automation of genetic testing accelerates raw material development by eliminating routine tasks. The asset value of 7.66, as tracked on this chart, reflects the company's current total debt-to-equity ratio.

This ratio, defined as the ratio of total liabilities to equity, measures the issuer's degree of financial autonomy and leverage level. By analyzing the company's debt history, an investor will see that the current liquidity of Moolec Science SA (MLEC) offsets the risks associated with regulatory approval for GMO soy, ensuring business resilience during the product commercialization phase without a critical dependence on borrowed funds.